首页> 中文期刊> 《山东医药》 >骨髓增生性疾病患者的血清TNFα及白细胞介素变化

骨髓增生性疾病患者的血清TNFα及白细胞介素变化

         

摘要

采用ELISA法或RIA法对26例骨髓增生性疾病(MPD)患者的肿瘤坏死因子(TNFα)、白细胞介素2及其受体(IL-2/sIL-2R)、白细胞介素6及其受体(IL-6/sIL-6R)和β2-MG水平进行了检测。发现MPD患者血清IL-2、β2-MG显著高于正常对照组,TNFα有升高趋势,IL-6/sIL-6R水平与对照组无显著性差异。病情活动或转化为急性白血病时,IL-2/sIL-2R和β2-MG均显著升高,提示这三项指标可作为判断MPD病情活动的参数。%Serum TNFα and interleukins were measured in 26 patients withmyeloproliferative disorders(MPD)by ELISA or RIA method.Elavated IL-2 and β2-MG levels were found in MPD patients,TNFα was slightly increased.There were no difference of IL-6 and sIL-6R levels between MPD and normal controls.In progressive disease and particularly when transformation to acute leukemia occurred,high levels of IL-2,sIL-2R and β2-MG were found in all patients.These results suggest that IL-2,sIL-2R and β2-MG could be as a potential prognostic usefulness in the individual patients.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号